Navi Mumbai, India (PressExposure) November 02, 2009 -- Opportunity Analysis of H1N1 (swine flu) Vaccination Market report ( [http://www.bharatbook.com/Market-Research-Reports/Opportunity-Analysis-of-H1N1-swine-fluVaccination-Market.html]) enables strategic understanding and opportunities in H1N1 Influenza A (2009) market. The first pandemic influenza of 21st century affecting more than 400000 people in more than 180 countries across the globe in 2009. The flu broke in Mexico in the month of March and then affected U.S. and after that it spread across the globe. H1N1 (2009) influenza have a mutation of pig, bird and humans which has made it more dangerous and fatal compared to previous occurrence of H1N1 (1918).
The pandemic outbreak of the influenza opened the gates for the drugs such as Tamiflu in the initial phase for the curing of the disease but the following phase will see a shift from curing to prevention. Thus, arise the requirement for the vaccine for the treatment of H1N1. H1N1 vaccine market is the forecast for the upcoming vaccines for the prevention of the disease among the unaffected population. The vaccines market is classified for the intramuscular vaccines and intranasal vaccines. Intramuscular will cater 80-85% of market revenues and the remaining will be tapped by the intranasal vaccines. The initial lot of vaccines will be of egg based and cell based manufacturing. The market forecast is from late 2009 as the first lot of doses are expected to be rolled out in the first week of October 2009.
The first movers of the in the vaccines market are Glaxo Smith Kline (GSK), Novartis, CSL, Medimmune, Baxter, Sinovec and Sanofi Pastuer. Medimmune is the only producer of the intranasal vaccine whereas other companies are expected to come out with intramuscular vaccines. The companies have got approvals for their first lots from the governments of the various countries such as U.S., U.K., France, China, Denmark and Australia. The involvement of government bodies, increased awareness about prevention and pandemic situation of the influenza is driving the market for the vaccines. Due to intensive ongoing research and technology introduction, the market players are compelled to understand the market dynamics, innovations, pricing, products, marketing and regulatory framework of the market.
The global H1N1 Influenza vaccine market is estimated to be of 676 million in 2009 with first lot of doses being commercialized on 30th Septemberâ 2009. The market will see a high CAGR for the next two years i.e. the market is expected to be at $7.03 billion in 2011 with a CAGR of 222.4% from 2009 to 2011. However, the very high CAGR will settle down by 2012 to 30% for the period of 2009 to 2012. The reason for the sudden settle down of the growth is that it is expected that most of the world population will be immunized by the end of 2011.
Market estimates and forecast
* This report will enable strategic understanding and opportunities in the H1N1 2009 influenza vaccines market. The report covers the following market segments. * Vaccines Markets: Intramuscular Vaccines and Intranasal vaccines. * Geography Markets: North America, Europe, Asia-Pacific and ROW
Each section of the report offers market data with respect to segments and geography. It also provides market trends with respect to drivers, restraints and opportunities. The report contains strategic section with respect to competitive landscape and market overview. The report will encompass around 15 company profiles.
To know more and to buy a copy of your report feel free to visit : [http://www.bharatbook.com/Market-Research-Reports/Opportunity-Analysis-of-H1N1-swine-fluVaccination-Market.html]
Contact us at : Â Bharat Book Bureau Tel: +91 22 27578668 Fax: +91 22 27579131 Email: email@example.com Website: http://www.bharatbook.com Blog: [http://bharatbookresearch.blogspot.com] Follow us on twitter: http://twitter.com/3bbharatbook